With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Abbott and Reckitt's Mead Johnson will not be allowed to show jurors a statement by U.S. government agencies and a government ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model ...

Abbott Laboratories ABT is slated to report its third-quarter 2024 results on Oct. 16, before the opening bell. The company ...

Key Takeaways Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical ...

Pharma companies also are known for paying dividends, offering you a guaranteed stream of annual revenue. Below are three ...

To help affected families and communities, Abbott and Abbott Fund are working with our longstanding disaster relief partner ...

Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign ...

Abbott Laboratories (ABT) reports robust sales growth in key segments despite challenges in nutrition and diagnostics.